← FDA DRUG APPROVALS

FDA ANDA · ANDA204043

MYCOPHENOLATE MOFETIL HYDROCHLORIDE

Sponsor: RISING

APPLICATION
ANDA204043
TYPE
ANDA
ORIGINAL APPROVAL
2017-02-28
LATEST ACTION
2026-07-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

MYCOPHENOLATE MOFETIL HYDROCHLORIDEPrescription
MYCOPHENOLATE MOFETIL HYDROCHLORIDE 500MG/VIAL · INJECTABLE · INJECTION

Approval history

2026-07-29REMS · Supplement 18AP
2024-08-13REMS · Supplement 16AP
2024-07-03Labeling · Supplement 14 · standardAP
2024-07-03Labeling · Supplement 6 · standardAP
2024-07-03Labeling · Supplement 15 · standardAP
2021-08-11REMS · Supplement 11AP
2021-04-21REMS · Supplement 9AP
2021-01-15REMS · Supplement 8AP
2019-11-27Labeling · Supplement 3 · standardAP
2019-11-27Labeling · Supplement 1 · standardAP
2019-11-27Labeling · Supplement 4 · standardAP
2017-02-28UNKNOWN · OriginalREMSAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →